NASDAQ · CCLDO

CareCloud, Inc.. 8. 75% Cumulative Redeemable Perpetual

$27.44 -$0.06 (-0.22%) 1D
Session Pulse Pre-market 2 mentions on Fri No new SEC filings since Mon close its sector ranked 9/11 this week Full pulse →

Key Metrics

$653.45M
Market cap
66.87×
P/E · TTM
$124.14M
Revenue · TTM
$9.77M
Net income
EPS · TTM $0.41
Dividend yield
Free cash flow $22.49M
Beta · 1Y 0.33
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K/A - CareCloud, Inc. (0001582982) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 24
    An insider transaction hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$19.72 – $27.51
Avg volume · 20D8.2K
Net cash
Book value / share$2.45
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About CareCloud, Inc.. 8. 75% Cumulative Redeemable Perpetual
IPO dateFeb 3, 2022
Employees3650

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E66.87
P/S5.26
P/FCF29.05
EV/EBITDA
EV/Sales
Graham №$4.76

Profitability

Gross
Operating 8.0%
Net 7.9%
FCF 18.1%
ROE / ROIC 18.1% · —

Financial Health

Current ratio1.11
Quick ratio1.09
Debt / equity
Debt / EBITDA
Net cash
Working capital$2.63M

Cash Flow · TTM

Operating CF $27.06M
Capex −$4.57M
Free cash flow $22.49M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

14.8
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$4.76 vs $27.44
Trades 5.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings